TLRY - Tilray Brands Inc
IEX Last Trade
1.71
0.010 0.585%
Share volume: 14,326,926
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.70
0.01
0.59%
Fundamental analysis
24%
Profitability
0%
Dept financing
7%
Liquidity
75%
Performance
40%
Performance
5 Days
-11.40%
1 Month
-14.93%
3 Months
-5.00%
6 Months
-2.29%
1 Year
-35.71%
2 Year
-34.48%
Key data
Stock price
$1.71
DAY RANGE
N/A - N/A
52 WEEK RANGE
$1.50 - $3.40
52 WEEK CHANGE
-$0.43
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/03/2024
Company detail
CEO: Brendan Kennedy
Region: US
Website: https://www.tilray.com/
Employees: 437
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.tilray.com/
Employees: 437
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. we are the only gmp certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in australia, canada, the european union and the americas.
Recent news